NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.
The researchers intend to develop systems that can separate out and sort whole chromosomes from one cell or from multiple cells. The company expects the new system to enable sorting of sub-cellular components by size, which will enable a number of analytic applications, including sequencing, mapping, and epigenetics, “in a real-time, dynamic, bench-top format.”
BioNanomatrix, based in Philadelphia, is a Princeton spin-out, and has exclusively licensed its technology from the school.